Page last updated: 2024-09-04

perifosine and xl765

perifosine has been researched along with xl765 in 1 studies

Compound Research Comparison

Studies (perifosine)	Trials (perifosine)	Recent Studies (post-2010) (perifosine)	Studies (xl765)	Trials (xl765)	Recent Studies (post-2010) (xl765)
245	31	140	33	10	32

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boratyn, E; Durbas, M; Horwacik, I; Kamycka, E; Rokita, H	1

Other Studies

1 other study(ies) available for perifosine and xl765

Article	Year
GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines. International journal of oncology, 2015, Volume: 47, Issue:3 Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Drug Synergism; Gangliosides; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Neuroblastoma; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Quinolines; Quinoxalines; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases	2015

Article

Year

GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines.

International journal of oncology, 2015, Volume: 47, Issue:3

Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Drug Synergism; Gangliosides; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Neuroblastoma; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Proto-Oncogene Proteins c-akt; Quinolines; Quinoxalines; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases

2015